pkc inhibitor peptide protein kinase C - rhode-by-hailey-bieber-peptide-lip-set Inhibitor Understanding PKC Inhibitor Peptides: A Deep Dive into Their Mechanism and Applications

pittsburgh-peptide-therapy Protein Kinase C (PKC) is a crucial family of enzymes that play a pivotal role in regulating a vast array of cellular processes, including cell growth, differentiation, apoptosis, and immune responses. The intricate signaling pathways mediated by PKC are tightly controlled, and dysregulation of these pathways can contribute to the development of various diseases, such as cancer and inflammatory disorders.Protein Kinase C (19-35) Peptide Consequently, PKC inhibitors have emerged as significant therapeutic agents and valuable research tools. Among the diverse classes of PKC inhibitors, PKC inhibitor peptides stand out due to their specificity and targeted action.

This article delves into the world of PKC inhibitor peptides, exploring their fundamental mechanisms of action, different types of peptides employed, and their wide-ranging applications in scientific research and potential therapeutic interventions. We will examine how these inhibitor peptides interact with Protein Kinase C to modulate its activity, with a focus on understanding the nuances of peptide-based inhibition.

The Mechanism of Action: How PKC Inhibitor Peptides Work

PKC inhibitor peptides primarily function by interfering with the activation and catalytic activity of Protein Kinase C. Two main strategies are employed by these peptides:

1. Pseudosubstrate Inhibition: Many PKC peptides are derived from the pseudosubstrate region of PKC itself. This region, normally located within the regulatory domain of the protein kinase C enzyme, mimics the actual substrate. When a peptide inhibitor mimics this pseudosubstrate, it binds to the active site of PKC, effectively blocking the binding of the natural substrate and thereby preventing phosphorylationepsilon-V1-2, epsilon-PKC Inhibitor. Examples of such peptides include those corresponding to residues 19-31 or 19-35 of PKC. The Protein Kinase C (19-31) (Synonyms: PKC (19-31)) and Protein Kinase C (19-35) Peptide are prime examples of this mechanism作者：AS Bogard·2015·被引用次数：40—In this study, we demonstrated that ZIP interacts with conventional and novelPKC, in addition to atypicalPKCisoforms.. Some of these pseudosubstrate peptides can be modified, such as becoming myristoylated, to enhance their cell permeability and efficacy, as seen with the myristoylated peptide, myr-psiPKC. This approach leads to a reversible and substrate competitive inhibitionThe kinase specificity of protein kinase inhibitor peptide.

2. Translocation Inhibition: Another significant class of PKC inhibitor peptides targets the translocation of specific PKC isoforms to cellular membranes, a critical step for their activation. For instance, PKC epsilon inhibitor peptide is designed to selectively and reversibly inhibit the translocation of Protein Kinase C epsilon. This type of inhibitor disrupts the interaction of the PKC isoform with its receptor for activated C kinase (RACK) or other anchoring proteins, thereby preventing the enzyme from reaching its site of action. The epsilon-V1-2, epsilon-PKC Inhibitor and PKC ε Translocation Inhibitor Peptide Negative Control are products that exemplify this mode of inhibition作者：AS Bogard·2015·被引用次数：40—In this study, we demonstrated that ZIP interacts with conventional and novelPKC, in addition to atypicalPKCisoforms.. The PKC ε inhibitor peptide (CAS 182683-50-7), corresponding to an amino acid sequence in the C2 domain of mammalian PKCε, also operates through influencing translocation.

Purity specifications for these peptides are crucial for reliable research, with many products boasting purity ≥97%. The molecular weight of these peptides often falls in the range of approximately 844–1500 Daltons, depending on the length and modifications. It's important to note that some specific PKC inhibitor peptide products, such as PKC Inhibitor Peptide 19-36, are no longer available.

Types of PKC Inhibitor Peptides and Isoform Specificity

The Protein Kinase C family comprises multiple isoforms, broadly classified into conventional (cPKC), novel (nPKC), and atypical (aPKC) subgroups. PKC inhibitor peptides can be engineered for high specificity towards particular isoforms, making them powerful tools for dissecting the roles of individual PKC enzymes.Activators and Inhibitors of Protein Kinase C (PKC) - PMC - NIH

* PKC ε Isoform Specific Inhibitors: A significant focus in the development of PKC inhibitor peptides has been on PKC epsilon (PKC ε). This isoform is implicated in numerous cellular functions, including neurotransmitter release and cell survival. PKC ε inhibitor peptides like epsilon-V1-2 and those targeting PKC ε translocation are vital for studying its specific contributions to cellular signaling.

* Inhibitors of Other Isoforms: Beyond PKC ε, researchers have developed peptides targeting other PKC isoforms. For example, PCI α (C2-4) Inhibitor Peptide is designed to block PKC α activity. Similarly, PKC δ (8-17), derived from the V1 domain of PKC δ, inhibits PMA-induced PKC δ translocation.Protein Kinase C: Structure, Function, and Regulation - ScienceDirect PKC ζ pseudosubstrate and PKC β pseudosubstrate are engineered to specifically target PKC ζ and PKC β, respectively.

Applications of PKC Inhibitor Peptides

The precise and often isoform-specific targeting capabilities of PKC inhibitor peptides make them indispensable in various fields:

* Research Tool: In basic scientific research, these peptides are instrumental in elucidating the downstream signaling pathways regulated by specific PKC isoforms. By blocking the activity of a particular PKC, researchers can observe the subsequent cellular responses and infer the function of that isozyme.作者：M Zerihun·2023·被引用次数：10—This approach has proven successful for theinhibitionof actions of specific isoforms ofprotein kinase C(PKC) [62,63]. (2)Peptidesderived from similarity ... Understanding protein kinase C signaling is crucial for many biological investigations.

* Drug Discovery and Development: The dysregulation of PKC activity is linked to numerous diseases, including various forms of cancer, inflammatory conditions, and neurological disordersEffect of protein kinase C (PKC) inhibitor peptide 19-27 .... PKC inhibitor peptides serve as lead compounds or models for the development of more potent and pharmacologically viable small molecule drugs. Their ability to demonstrate inhibition with specific Ki values, such as 0.15 µM for a potent PKC inhibitor peptide, highlights their efficacy.PKC inhibitoris an activepeptidepotent inhibitor of PKC (Ki of 0.15 μM); no significant inhibition of cAMP-dependent protein kinases (IC50>400 μM)

* Investigating Cellular Processes: PKC plays a role in diverse cellular processes. For example, PKC ε mediated signal transduction is investigated for its role in cell signaling and neuronal function. PKC inhibitor research often focuses on understanding how inhibition impacts these complex networks.

It is important to understand the comprehensive range of PKC inhibitors, which also include small molecule compounds like Staurosporine (STS). While STS is a potent PKC inhibitor for isoforms like PKC α, PKC γ, and PKC η with very low IC50 values, PKC peptides offer a different approach to inhibition, often with greater selectivityArticles Functional Deactivation of the Major Neuronal Nicotinic Receptor ....

In summary, PKC inhibitor peptides represent a sophisticated class of molecular tools that enable precise manipulation of Protein Kinase C signaling. Their design, based on mimicking natural regulatory mechanisms or disrupting essential protein-protein interactions, allows for targeted inhibition and a deeper understanding of PKC's multifaceted roles in health and disease. As research progresses, these peptides will undoubtedly continue to be vital in advancing our knowledge and developing novel therapeutic strategies.